Blog

Patrick Forde: Great day for lung cancer care

Patrick Forde/Facebook

Feb 22, 2025, 15:54

Patrick Forde: Great day for lung cancer care

Patrick Forde, Professor at Johns Hopkins University and Co-Director of the Division of Upper Aerodigestive Malignancies at the Sidney Kimmel Comprehensive Cancer Center, reshared a post by Bristol Myers Squibb on X, adding:

“Great day for lung cancer care!

Addition of just 3 cycles of nivolumab immunotherapy to standard neoadjuvant chemo leads to improved overall survival for surgically resectable lung cancer!”

Quoting Bristol Myers Squibb‘s post:

“MEDIA:

Announcing the final analysis of OS from the CheckMate -816 trial evaluating our immunotherapy used in combination with chemotherapy regimen as neoadjuvant treatment of resectable non-small cell lung cancer.”

Patrick Forde: Great day for lung cancer care

Bristol Myers Squibb cancer CheckMate -816 trial chemotherapy fight against cancer Global fight against cancer immunotherapy Johns Hopkins University Lung cancer non small cell lung cancer NSCLC OncoDaily Oncology Patrick Forde Sidney Kimmel Comprehensive Cancer Center

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity